Subtopic Deep Dive

Epithelial-Mesenchymal Transition
Research Guide

What is Epithelial-Mesenchymal Transition?

Epithelial-mesenchymal transition (EMT) is a reversible process where epithelial cancer cells lose polarity and cell-cell adhesion to acquire mesenchymal motility and invasiveness, enabling metastasis.

EMT drives tumor progression by promoting cancer cell migration and resistance to therapies (Kalluri and Weinberg, 2009, 9930 citations; Thiery et al., 2009, 9808 citations). It links to stem cell properties and stromal interactions in the tumor microenvironment (Mani et al., 2008, 8626 citations). Over 10 highly cited papers from 2004-2013 establish its core mechanisms.

15
Curated Papers
3
Key Challenges

Why It Matters

EMT inhibition targets metastatic spread, the leading cause of cancer deaths, by blocking motility regulators like Twist (Yang et al., 2004, 3807 citations) and Snail factors. It underlies therapy resistance and stemness in breast and other cancers (Mani et al., 2008; Chaffer and Weinberg, 2011, 4801 citations). Stromal purity estimation refines EMT studies in heterogeneous tumors (Yoshihara et al., 2013, 10335 citations), guiding precision therapies against invasion.

Key Research Challenges

Quantifying EMT Heterogeneity

Tumors mix epithelial, mesenchymal, and hybrid states, complicating measurement amid stromal admixture (Yoshihara et al., 2013). Single-cell resolution remains limited in bulk data. Dynamic reversibility evades static markers (Chaffer and Weinberg, 2011).

Decoupling EMT from Stemness

EMT induces stem-like properties, but causality versus correlation persists (Mani et al., 2008). Transcription factors like Twist drive both, hindering selective targeting (Yang et al., 2004). Therapy exploits this link ineffectively.

Targeting Transient EMT States

Partial EMT hybrids promote invasion more than full transitions (Polyák and Weinberg, 2009, 3264 citations). Microenvironment cues like ECM trigger reversibility (Lu et al., 2012, 2932 citations). Inhibitors fail against dynamic shifts.

Essential Papers

1.

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez et al. · 2013 · Nature Communications · 10.3K citations

Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and not only perturb the tumour signal in molecular studies but also have an important role in cancer ...

2.

The basics of epithelial-mesenchymal transition

Raghu Kalluri, Robert A. Weinberg · 2009 · Journal of Clinical Investigation · 9.9K citations

The origins of the mesenchymal cells participating in tissue repair and pathological processes, notably tissue fibrosis, tumor invasiveness, and metastasis, are poorly understood. However, emerging...

3.

Epithelial-Mesenchymal Transitions in Development and Disease

Jean Paul Thiery, Hervé Acloque, Ruby Yun‐Ju Huang et al. · 2009 · Cell · 9.8K citations

4.

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

Sendurai A. Mani, Wenjun Guo, Mai-Jing Liao et al. · 2008 · Cell · 8.6K citations

5.

A Perspective on Cancer Cell Metastasis

Christine L. Chaffer, Robert A. Weinberg · 2011 · Science · 4.8K citations

Metastasis causes most cancer deaths, yet this process remains one of the most enigmatic aspects of the disease. Building on new mechanistic insights emerging from recent research, we offer our per...

6.

Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis

Jing Yang, Sendurai A. Mani, Joana Liu Donaher et al. · 2004 · Cell · 3.8K citations

7.

A framework for advancing our understanding of cancer-associated fibroblasts

Erik Sahai, Igor Astsaturov, Edna Cukierman et al. · 2020 · Nature reviews. Cancer · 3.5K citations

Abstract Cancer-associated fibroblasts (CAFs) are a key component of the tumour microenvironment with diverse functions, including matrix deposition and remodelling, extensive reciprocal signalling...

Reading Guide

Foundational Papers

Start with Kalluri and Weinberg (2009) for EMT basics and Thiery et al. (2009) for development-disease context, then Mani et al. (2008) for stemness mechanisms and Yang et al. (2004) for Twist regulation.

Recent Advances

Yoshihara et al. (2013) for tumor purity in EMT analysis; Chaffer and Weinberg (2011) for metastasis perspective; Sahai et al. (2020) for CAF-EMT interactions.

Core Methods

ESTIMATE algorithm deconvolves stromal signals (Yoshihara et al., 2013); Twist overexpression models metastasis (Yang et al., 2004); marker panels track transitions (Mani et al., 2008).

How PapersFlow Helps You Research Epithelial-Mesenchymal Transition

Discover & Search

Research Agent uses citationGraph on Kalluri and Weinberg (2009) to map 50+ EMT-metastasis papers, then exaSearch for 'TGF-β Snail EMT cancer resistance' to find regulators, and findSimilarPapers on Thiery et al. (2009) for development-disease links.

Analyze & Verify

Analysis Agent applies readPaperContent to Mani et al. (2008) for stemness data, runPythonAnalysis on expression matrices from Yoshihara et al. (2013) to estimate stromal purity via ESTIMATE scores, and verifyResponse with CoVe plus GRADE grading to validate EMT marker overlaps statistically.

Synthesize & Write

Synthesis Agent detects gaps in Twist targeting post-Yang et al. (2004), flags EMT-stemness contradictions from Chaffer and Weinberg (2011), then Writing Agent uses latexEditText for reviews, latexSyncCitations across 20 papers, and latexCompile for manuscripts with exportMermaid diagrams of EMT networks.

Use Cases

"Analyze EMT stemness link in breast cancer from Mani 2008"

Research Agent → searchPapers 'Mani EMT stem cells' → Analysis Agent → readPaperContent + runPythonAnalysis (pandas correlation of CD44/ALDH1 markers) → CSV export of verified stemness gene scores.

"Draft LaTeX review on Twist in EMT metastasis"

Synthesis Agent → gap detection on Yang 2004 → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (10 papers) → latexCompile → PDF with EMT regulator diagram.

"Find code for estimating tumor purity in EMT studies"

Research Agent → paperExtractUrls on Yoshihara 2013 → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python sandbox run of ESTIMATE algorithm on TCGA data.

Automated Workflows

Deep Research workflow scans 50+ EMT papers via searchPapers → citationGraph → structured report with GRADE-scored mechanisms from Kalluri 2009 and Thiery 2009. DeepScan applies 7-step CoVe to verify Twist-EMT causality (Yang 2004) with runPythonAnalysis checkpoints. Theorizer generates hypotheses on hybrid EMT targeting from Polyák 2009 gaps.

Frequently Asked Questions

What defines epithelial-mesenchymal transition?

EMT is the conversion of polarized epithelial cells to motile mesenchymal cells via loss of E-cadherin and gain of N-cadherin/Vimentin (Kalluri and Weinberg, 2009). It enables invasion in cancer (Thiery et al., 2009).

What methods study EMT in tumors?

Expression analysis estimates stromal admixture with ESTIMATE (Yoshihara et al., 2013). Transcription factors like Twist are assayed via qPCR/Western blot (Yang et al., 2004). Single-cell RNA-seq resolves hybrid states.

What are key papers on EMT?

Kalluri and Weinberg (2009, 9930 citations) covers basics; Mani et al. (2008, 8626 citations) links to stemness; Yang et al. (2004, 3807 citations) establishes Twist role.

What open problems exist in EMT research?

Distinguishing causal EMT drivers from passengers in metastasis (Chaffer and Weinberg, 2011). Targeting reversible hybrid states (Polyák and Weinberg, 2009). Integrating ECM-stromal effects (Lu et al., 2012).

Research Cancer Cells and Metastasis with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Epithelial-Mesenchymal Transition with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers